NCT07351929Active, not recruiting
Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD
An Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD (EmoD) - A Feasibility Study
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
The investigators have developed a new counseling service that focuses on the emotional distress experienced by people living with COPD. The service has been specially developed for patients who have experienced a deterioration in their lung condition (known as an acute exacerbation of COPD). The new program is led by an APN team. Other professionals are involved in the program, such as medical staff and physiotherapists. The new counseling service lasts three months. Patients will receive ten counseling sessions with a specialized nurse. The overall objective of the study is to assess the feasibility of the newly developed emotional-distress-based integrated care programme.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 14 Nov 2025
- Start date
- 12 Jan 2026
- Primary completion date
- 10 Sept 2026
- Lead sponsor
- University of Zurich
- Diseases
- COPD
- NCT number
- NCT07351929
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 12 Jan 2026 to the primary completion date, 10 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Lung transplant
Other illness
- Cognitive impairment (dementia, delirium) (DOS\>3 or AES\>6 or Mini-Cog\<3)
- Unstable psychiatric disorders
Other
- Not speaking German
- Pneumonia caused by chronic colonization by bacteria (Legionella, nontuberculous mycobacteria (NTM))
- Unable to telephone
Who the study is looking for
- Patients with a confirmed diagnosis of COPD (GOLD 1-4)
- Hospitalisation due to a COPD exacerbation and decision to start with steroids and/or antibiotics (severe exacerbation)
- Age ≥ 18
- Inpatient on the pneumology or medical ward
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Zurich Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.